COMMUNIQUÉS West-GlobeNewswire
-
Aptose to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update on Tuesday, March 26, 2024
18/03/2024 - 21:30 -
Homology Medicines Declares Distribution to Common Stockholders
18/03/2024 - 21:30 -
Arvinas Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer
18/03/2024 - 21:40 -
QDOSE® Platform Partnership for Personalized Dosimetry in Radiopharmaceutical Therapy
18/03/2024 - 22:08 -
Outlook Therapeutics® Announces Closing of Private Placement of up to $159 Million
18/03/2024 - 22:10 -
Merit Medical Systems to Announce First Quarter 2024 Results on April 30, 2024
18/03/2024 - 22:19 -
Progyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum
18/03/2024 - 17:00 -
TaiMed Biologics and AcedrA BioPharmaceuticals Partner to Commercialize Trogarzo® (Ibalizumab-uiyk) in the Middle East and North Africa Region
18/03/2024 - 17:19 -
Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023
18/03/2024 - 19:18 -
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
18/03/2024 - 19:18 -
T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel
18/03/2024 - 14:00 -
Inside Information: Additional Positive Data from the Phase 1 Part of the BEXMAB Study in Both Higher-Risk HMA-Failed MDS and r/r AML
18/03/2024 - 14:00 -
Parexel Announces CEO Succession Plan
18/03/2024 - 14:05 -
Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023
18/03/2024 - 15:00 -
Medigene AG to report full year 2023 financial results on March 28, 2024
18/03/2024 - 15:00 -
Novo Nordisk A/S - share repurchase programme
18/03/2024 - 15:18 -
Novonesis will host a conference call regarding 2024 outlook and 2023 pro forma financials on March 21
18/03/2024 - 15:26 -
RS BioTherapeutics Selected for Presentation at American Thoracic Society’s 2024 Respiratory Innovation Summit
18/03/2024 - 16:30 -
CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies
18/03/2024 - 11:00
Pages